Creative Planning Dynavax Technologies Corp Transaction History

Creative Planning

  • $93.6 Billion
  • Q2 2024

A detailed history of Creative Planning transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Creative Planning holds 15,135 shares of DVAX stock, worth $168,603. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,135
Previous 11,352 33.32%
Holding current value
$168,603
Previous $140,000 20.71%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024
BUY
$10.73 - $12.58 $40,591 - $47,590
3,783 Added 33.32%
15,135 $169,000
Q1 2024

May 10, 2024
BUY
$11.7 - $14.98 $6,470 - $8,283
553 Added 5.12%
11,352 $140,000
Q4 2023

Feb 14, 2024
SELL
$13.09 - $14.98 $3,769 - $4,314
-288 Reduced 2.6%
10,799 $150,000
Q3 2023

Nov 16, 2023
SELL
$12.64 - $14.99 $12,071 - $14,315
-955 Reduced 7.93%
11,087 $163,000
Q2 2023

Jul 21, 2023
BUY
$9.85 - $13.17 $118,613 - $158,593
12,042 New
12,042 $155,000
Q2 2022

Aug 15, 2022
SELL
$7.45 - $12.83 $80,251 - $138,204
-10,772 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$9.75 - $14.44 $40,316 - $59,709
-4,135 Reduced 27.74%
10,772 $117,000
Q4 2021

Feb 11, 2022
BUY
$13.17 - $20.94 $196,325 - $312,152
14,907 New
14,907 $210,000
Q4 2020

Jan 29, 2021
SELL
$3.73 - $5.6 $43,573 - $65,419
-11,682 Closed
0 $0
Q3 2020

Nov 05, 2020
SELL
$4.32 - $11.7 $21,816 - $59,085
-5,050 Reduced 30.18%
11,682 $50,000
Q2 2020

Jul 23, 2020
BUY
$2.94 - $9.1 $49,192 - $152,261
16,732 New
16,732 $148,000
Q4 2019

Jan 30, 2020
SELL
$3.46 - $6.93 $54,778 - $109,715
-15,832 Closed
0 $0
Q2 2019

Jul 26, 2019
SELL
$3.65 - $7.89 $803,000 - $1.74 Million
-220,000 Reduced 93.29%
15,832 $63,000
Q1 2019

Apr 24, 2019
BUY
$7.08 - $12.09 $14,528 - $24,808
2,052 Added 0.88%
235,832 $1.72 Million
Q4 2018

Feb 01, 2019
SELL
$8.14 - $13.28 $4,884 - $7,968
-600 Reduced 0.26%
233,780 $2.14 Million
Q3 2018

Oct 25, 2018
SELL
$11.85 - $16.0 $8,591 - $11,600
-725 Reduced 0.31%
234,380 $2.91 Million
Q2 2018

Jul 20, 2018
BUY
$15.15 - $20.75 $88,733 - $121,532
5,857 Added 2.55%
235,105 $3.59 Million
Q1 2018

Apr 18, 2018
SELL
$14.65 - $19.9 $23,440 - $31,839
-1,600 Reduced 0.69%
229,248 $4.55 Million
Q4 2017

Jan 17, 2018
BUY
$17.3 - $24.08 $1.37 Million - $1.9 Million
79,025 Added 52.05%
230,848 $4.32 Million
Q3 2017

Oct 17, 2017
BUY
$15.2 - $21.5 $2.31 Million - $3.26 Million
151,823
151,823 $3.26 Million

Others Institutions Holding DVAX

# of Institutions
259
Shares Held
132M
Call Options Held
371K
Put Options Held
99.2K
View Full List

About DYNAVAX TECHNOLOGIES CORP

DVAX Quotes by TradingView
  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.41B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email